Hypoxia, HIF1 and glucose metabolism in the solid tumour
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
It has been known for many years that cellular metabolism within the solid tumour is markedly different from that of the corresponding normal tissue. The transcription factor hypoxia-inducible factor 1 (HIF1) has been implicated in regulating many of the genes that are responsible for the metabolic difference. However, it remains unclear how this 'aerobic glycolysis', originally described by Otto Warburg, offers tumour cells a growth advantage. As discussed in this Perspective, new data suggests that this metabolic switch may provide a benefit to the tumour not by increasing glycolysis but by decreasing mitochondrial activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated HIF-1 plays a crucial role in adaptive responses of the tumor cells to changes in oxygen through transcriptional activation of over 100 downstream genes which regulate vital biological processes required for tumor survival and progression.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1 mediates this metabolic conversion through the induction of enzymes involved in the glycolysis pathway and overexpression of glucose transporters (GLUTs) which increase glucose import into tumor cells3.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1α is activated due to blockade of its degradation pathway mediated by low oxygen levels, thereby increasing the expression of target genes, including those encoding glycolytic enzymes and glucose transporters, and increasing lactate secretion67.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [67]
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“Tumour cells respond to these conditions, and adapt their metabolism to adjust the O 2 demand to meet the limited suppl”
Background
Cited by
Items 301–400 of 1,002
The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells
Smolková, K., & Ježek, P. (2012) · International Journal of Cell Biology · doi:10.1155/2012/273947 · Cited by 106
Rivadeneira, D. B., Caino, M. C., Seo, J. H., Angelin, A., Wallace, D. C., Languino, L. R., & Altieri, D. C. (2015) · Science Signaling · doi:10.1126/scisignal.aab1624 · Cited by 121
Srivastava, A., & Creek, D. J. (2018) · PROTEOMICS · doi:10.1002/pmic.201700448 · Cited by 117
Lu, H., Lin, J., Xu, C., Sun, M., Zuo, K., Zhang, X., Li, M., Huang, H., Li, Z., Wu, W. H., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.334 · Cited by 121
Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
Nakano, A., Tsuji, D., Miki, H., Cui, Q., Sayed, S. M. E., Ikegame, A., Oda, A., Amou, H., Nakamura, S., Harada, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027222 · Cited by 130
Zhang, R., Li, J., Zhang, T., Amini, M. A., He, C., Lu, B., Ahmed, T., Lip, H., Rauth, A. M., & Wu, X. Y. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.33 · Cited by 121
The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance
Woolbright, B. L., Choudhary, D., Mikhalyuk, A., Trammel, C. J., Shanmugam, S., Abbott, E., Pilbeam, C. C., & Taylor, J. A. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0063 · Cited by 112
PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis
Qin, Y., Hu, Q., Xu, J., Ji, S., Dai, W., Liu, W., Xu, W., Sun, Q., Zhang, Z., Ni, Q., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0344-4 · Cited by 118
A Dual Functional Nanoreactor for Synergistic Starvation and Photodynamic Therapy
Zhu, Y., Shi, H., Li, T., Yu, J., Guo, Z., Cheng, J., & Liu, Y. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c01039 · Cited by 115
Rezaeian, A.-H., Li, C.-F., Wu, C.-Y., Zhang, X., Delacerda, J., You, M. J., Han, F., Cai, Z., Jeong, Y. S., Jin, G., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3445 · Cited by 109
Tumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin
Cao, Y., Eble, J. M., Moon, E., Yuan, H., Weitzel, D. H., Landon, C. D., Yu-Chih Nien, C., Hanna, G., Rich, J. N., Provenzale, J. M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1345 · Cited by 111
“HIF-1 is a master transcriptional activator regulating hundreds of vital genes in all steps of tumorigenesis and tumor progression including angiogenesis (1), proliferation / apoptosis (2), therapeutic resistance (1, 3), cancer stem cell maintenance / reprogramming (4), invasion / metastasis (1), and energy metabolism…”
Wu, C.-A., Chao, Y., Shiah, S., & Lin, W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.01.025 · Cited by 125
Li, L., Yang, L., Fan, Z., Xue, W., Shen, Z., Yuan, Y., Sun, X., Wang, D., Lian, J., Wang, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0152-8 · Cited by 109
Zhang, F., Liu, H., Duan, M., Wang, G., Zhang, Z., Wang, Y., Qian, Y., Yang, Z., & Jiang, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01304-5 · Cited by 126
The Warburg Effect Suppresses Oxidative Stress Induced Apoptosis in a Yeast Model for Cancer
Ruckenstuhl, C., Büttner, S., Carmona‐Gutiérrez, D., Eisenberg, T., Kroemer, G., Sigrist, S. J., Fröhlich, K., & Madeo, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004592 · Cited by 112
Hypoxia-Inducible Factor 1α Mediates Anoikis Resistance via Suppression of α5 Integrin
Rohwer, N., Welzel, M., Daskalow, K., Pfander, D., Wiedenmann, B., Detjen, K., & Cramer, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1839 · Cited by 109
Chen, F., Zhuang, M., Zhong, C., Peng, J., Wang, X., Li, J., Chen, Z., & Huang, Y. (2014) · Oncology Reports · doi:10.3892/or.2014.3550 · Cited by 116
Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma
Eckert, A. W., Wickenhauser, C., Salins, P. C., Kappler, M., Bukur, J., & Seliger, B. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0828-6 · Cited by 118
Lyu, X., Wang, J., Guo, X., Wu, G., Yang, J., Faleti, O. D., Liu, P., Liu, T., Long, Y., Chong, T., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007484 · Cited by 115
Metabolic adaptation supports enhanced macrophage efferocytosis in limited-oxygen environments
Wang, Y., Trzeciak, A. J., Rojas, W. S., Saavedra, P. H. V., Chen, Y., Chirayil, R., Etchegaray, J. I., Lucas, C. D., Puleston, D. J., Keshari, K. R., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.005 · Cited by 122
Eskian, M., Alavi, A., Khorasanizadeh, M., Viglianti, B. L., Jacobsson, H., Barwick, T. D., Meysamie, A., Yi, S. K., Iwano, S., Bybel, B., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4194-x · Cited by 109
Targeting ABL1-Mediated Oxidative Stress Adaptation in Fumarate Hydratase-Deficient Cancer
Sourbier, C., Ricketts, C. J., Matsumoto, S., Crooks, D. R., Liao, P., Mannes, P. Z., Yang, Y., Wei, M.-H., Srivastava, G. K., Ghosh, S., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.005 · Cited by 115
Wan, W., Peng, K., Li, M., Qin, L., Tong, Z., Yan, J., Shen, B., & Yu, C. (2017) · Oncogene · doi:10.1038/onc.2017.13 · Cited by 114
Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic Program
Tang, K., Zhu, L., Chen, J., Wang, D., Zeng, L., Chen, C., Tang, L. V., Zhou, L., Wei, K., Zhou, Y., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0753 · Cited by 119
Nicolle, R., Ayadi, M., Gomez‐Brouchet, A., Armenoult, L., Banneau, G., Elarouci, N., Tallegas, M., Decouvelaere, A., Aubert, S., Rédiní, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12525-7 · Cited by 111
Metabolic flexibility in melanoma: A potential therapeutic target
Ruocco, M. R., Avagliano, A., Granato, G., Vigliar, E., Masone, S., Montagnani, S., & Arcucci, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.016 · Cited by 113
ZBTB7A acts as a tumor suppressor through the transcriptional repression of glycolysisPreprint
Liu, X., Haines, J. E., Mehanna, E. K., GENET, M. D., Ben‐Sahra, I., Asara, J. M., Manning, B. D., & Yuan, Z.-M. (2014) · Genes & Development · doi:10.1101/gad.245910.114 · Cited by 108
Metabolic exchanges within tumor microenvironment
Chiarugi, P., & Cirri, P. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.027 · Cited by 109
Zhang, H., Zhang, G., Gonzalez, F. J., Park, S.-M., & Cai, D. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001112 · Cited by 101
Molecular Pathways: Mitochondrial Reprogramming in Tumor Progression and Therapy
Caino, M. C., & Altieri, D. C. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0460 · Cited by 105
Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells
Hajizadeh, F., Okoye, I., Esmaily, M., Chaleshtari, M. G., Masjedi, A., Azizi, G., Irandoust, M., Ghalamfarsa, G., & Jadidi‐Niaragh, F. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116952 · Cited by 112
Martin, S. P., Fako, V. E., Dang, H. T., Dominguez, D. A., Khatib, S. A., Ma, L., Wang, H., Zheng, W., & Wang, X. W. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01605-y · Cited by 109
Andersen, A. P., Moreira, J. M. A., & Pedersen, S. F. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0098 · Cited by 109
The Hallmarks of Cancer from a Redox Perspective
Hornsveld, M., & Dansen, T. B. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6580 · Cited by 115
New targets and therapeutic approaches for endocrine malignancies☆
Fassnacht, M., Kreissl, M. C., Weismann, D., & Allolio, B. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.013 · Cited by 107
Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy
Oliver, L., Olivier, C., Marhuenda, F., Campone, M., & Vallette, F. M. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902030263 · Cited by 111
Escaping Death: Mitochondrial Redox Homeostasis in Cancer Cells
Ciccarese, F., & Ciminale, V. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00117 · Cited by 108
Noncanonical Cell Fate Regulation by Bcl-2 Proteins
Chong, S. J. F., Marchi, S., Petroni, G., Kroemer, G., Galluzzi, L., & Pervaiz, S. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.03.004 · Cited by 107
HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia
Velasco-Hernandez, T., Hyrenius-Wittsten, A., Rehn, M., Bryder, D., & Cammenga, J. (2014) · Blood · doi:10.1182/blood-2014-04-567065 · Cited by 101
From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer
Saeed, M., Chen, F., Ye, J., Shi, Y., Lammers, T., Geest, B. G. D., Xu, Z. P., & Yu, H. (2021) · Advanced Materials · doi:10.1002/adma.202008094 · Cited by 108
Hypoxia and Senescence: The Impact of Oxygenation on Tumor Suppression
Welford, S. M., & Giaccia, A. J. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0065 · Cited by 108
Phosphoglycerate kinase 1 (PGK1) in cancer: A promising target for diagnosis and therapy
Fu, Q., & Yu, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117863 · Cited by 107
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2021) · Cancers · doi:10.3390/cancers13215557 · Cited by 109
Shen, G.-M., Zhang, F.-L., Liu, X.-L., & Zhang, J.-W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.09.040 · Cited by 99
Broekgaarden, M., Weijer, R., Krekorian, M., van den IJssel, B., Kos, M., Alles, L. K., van Wijk, A. C. W. A., Bikádi, Z., Hazai, E., van Gulik, T. M., et al. (2016) · Nano Research · doi:10.1007/s12274-016-1059-0 · Cited by 106
Guo, X., Qu, J., Zhu, C., Li, W., Luo, L., Yang, J., Yin, X., Li, Q., Du, Y., Chen, D., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1435751 · Cited by 101
Digging deeper through glucose metabolism and its regulators in cancer and metastasis
Ghanavat, M., Shahrouzian, M., Zayeri, Z. D., Banihashemi, S., Kazemi, S. M., & Saki, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118603 · Cited by 103
Autophagy: An adaptive metabolic response to stress shaping the antitumor immunity
Viry, E., Paggetti, J., Bagińska, J., Mgrditchian, T., Berchem, G., Moussay, E., & Janji, B. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.006 · Cited by 102
Ushio‐Fukai, M., Ash, D., Nagarkoti, S., de Chantemèle, E. J. B., Fulton, D. J., & Fukai, T. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8161 · Cited by 102
Whole Brain Radiation-Induced Vascular Cognitive Impairment: Mechanisms and Implications
Warrington, J. P., Ashpole, N., Csiszar, A., Lee, Y. W., Ungvari, Z., & Sonntag, W. E. (2013) · Journal of Vascular Research · doi:10.1159/000354227 · Cited by 98
Expression and significance of TLR4 and HIF-1α in pancreatic ductal adenocarcinoma
Zhang, J.-J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i23.2881 · Cited by 105
Imaging Tumor Hypoxia to Advance Radiation Oncology
Lee, C.-T., Boss, M., & Dewhirst, M. W. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5759 · Cited by 107
Li, W., Ma, X., Li, N., Liu, H., Dong, Q., Zhang, J., Yang, C., Liu, Y., Liang, Q., Zhang, S., et al. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.002 · Cited by 103
Yun, H. J., Li, M., Guo, D. S., Jeon, S. M., Park, S. H., Lim, J. S., Lee, S. B., Liu, R. R., Du, L., Kim, S., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02927-3 · Cited by 106
Yan, L., Wu, M., Wang, T., Yuan, H., Zhang, X., Zhang, H., Li, T., Pandey, V., Han, X., Lobie, P. E., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2390 · Cited by 110
Clinical value of whole-body PET/CT in patients with active rheumatic diseases
Yamashita, H., Kubota, K., & Mimori, A. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0423-2 · Cited by 98
Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
Conway, J. R. W., Herrmann, D., Evans, T. J., Morton, J. P., & Timpson, P. (2018) · Gut · doi:10.1136/gutjnl-2018-316822 · Cited by 104
STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma
Zhao, H., Yan, G., Zheng, L., Zhou, Y. J., Sheng, H., Wu, L., Zhang, Q., Lei, J., Zhang, J., Xin, R., et al. (2020) · Theranostics · doi:10.7150/thno.44025 · Cited by 97
Darekar, S., Georgiou, K., Yurchenko, M., Yenamandra, S. P., Chachami, G., Simos, G., Klein, G., & Kashuba, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042072 · Cited by 96
MicroRNA-183 upregulates HIF-1α by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells
Tanaka, H., Sasayama, T., Tanaka, K., Nakamizo, S., Nishihara, M., Mizukawa, K., Kohta, M., Koyama, J., Miyake, S., Taniguchi, M., et al. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-1027-9 · Cited by 108
Ježek, P., Plecitá‐Hlavatá, L., Smolková, K., & Rossignol, R. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.008 · Cited by 109
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
Ros, S., Flöter, J., Kaymak, I., Da Costa, C., Houddane, A., Dubuis, S., Griffiths, B., Mitter, R., Walz, S., Blake, S., et al. (2017) · Oncogene · doi:10.1038/onc.2016.477 · Cited by 83
Zhang, Y., Lin, L., Liu, L., Liu, F., Shu, S., Tian, H., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119255 · Cited by 96
Cyclic Peptide Screening Methods for Preclinical Drug Discovery
Li, X., Craven, T. W., & Levine, P. M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01077 · Cited by 96
Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer
Xia, P., An, H.-X., Dang, C.-X., Radpour, R., Kohler, C., Fokas, E., Engenhart-Cabillic, R., Holzgreve, W., & Zhong, X. Y. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-454 · Cited by 94
Metabolic insight into mechanisms of high-altitude adaptation in Tibetans
Ge, R.-L., Simonson, T. S., Cooksey, R. C., Tanna, U., Ga, Q., Huff, C. D., Witherspoon, D. J., Xing, J., Zhengzhong, B., Prchal, J. T., et al. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.03.003 · Cited by 106
Sakamoto, T., & Seiki, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.132704 · Cited by 103
Fu, D., Li, J., Wei, J., Zhang, Z., Luo, Y., Tan, H., & Ren, C. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0219-0 · Cited by 92
LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response
Ha, J. H., Radhakrishnan, R., Jayaraman, M., Yan, M., Ward, J. D., Fung, K., Moxley, K. M., Sood, A. K., Isidoro, C., Mukherjee, P., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1624 · Cited by 99
Regulators of glucose uptake in thyroid cancer cell lines
Heydarzadeh, S., Moshtaghie, A. A., Daneshpoor, M. S., & Hedayati, M. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00586-x · Cited by 102
Tang, X., Zhang, Q., Shi, S., Yen, Y., Li, X., Zhang, Y., Zhou, K., & Le, A. D. (2009) · International Journal of Cancer · doi:10.1002/ijc.24710 · Cited by 95
Janzen, C., Lei, M. Y. Y., Cho, J., Sullivan, P., Shin, B., & Devaskar, S. U. (2013) · Placenta · doi:10.1016/j.placenta.2013.08.010 · Cited by 103
Hypoxia induces differential translation of enolase/MBP-1
Sedoris, K. C., Thomas, S. D., & Miller, D. M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-157 · Cited by 103
Emerging roles for WNK kinases in cancer
Moniz, S., & Jordan, P. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0261-6 · Cited by 106
Fine, E. J., Miller, A., Quadros, E. V., Sequeira, J. M., & Feinman, R. D. (2009) · Cancer Cell International · doi:10.1186/1475-2867-9-14 · Cited by 92
Hypoxia-inducible factor-1 (HIF-1) promotes LDL and VLDL uptake through inducing VLDLR under hypoxia
Shen, G., Zhao, Y., Chen, M., Zhang, F., Liu, X., Wang, Y., Liu, C., Yu, J., & Zhang, J. (2011) · Biochemical Journal · doi:10.1042/bj20111377 · Cited by 103
Ji, S., Qin, Y., Liang, C., Huang, R., Shi, S., Liu, J., Jin, K., Liang, D., Xu, W., Zhang, B., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2380 · Cited by 96
“In vitro” 3D models of tumor-immune system interaction
Hirt, C., Papadimitropoulos, A., Mele, V., Muraro, M. G., Mengus, C., Iezzi, G., Terracciano, L., Martín, I., & Spagnoli, G. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.003 · Cited by 102
Estèves, P., Pecqueur, C., Ransy, C., Esnous, C., Lenoir, V., Bouillaud, F., Bulteau, A., Lombès, A., Prip‐Buus, C., Ricquier, D., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3383 · Cited by 95
Jha, M. K., Lee, I., & Suk, K. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.006 · Cited by 98
Riquelme, S. A., Lozano, C., Moustafa, A. M., Liimatta, K., Tomlinson, K. L., Britto, C. J., Khanal, S., Gill, S. K., Narechania, A., Azcona, J. M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav4634 · Cited by 97
A biomimetic 3D model of hypoxia-driven cancer progression
Liverani, C., Vita, A. D., Minardi, S., Kang, Y., Mercatali, L., Amadori, D., Bongiovanni, A., Manna, F. L., Ibrahim, T., & Tasciotti, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-48701-4 · Cited by 102
Lang, B. J., Guerrero-Gimenez, M. E., Prince, T. L., Ackerman, A., Bonorino, C., & Calderwood, S. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184507 · Cited by 100
Hypoxia‑inducible factors in hepatocellular carcinoma (Review)
Guo, Y., Xiao, Z., Liu, Y., Gao, Y., Zhu, Q., Hu, L., Huang, D., & Xu, Q. (2019) · Oncology Reports · doi:10.3892/or.2019.7397 · Cited by 120
RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer
Kang, R., Hou, W., Zhang, Q., Chen, R., Lee, Y. J., Bartlett, D. L., Lotze, M. T., Tang, D., & Zeh, H. J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.445 · Cited by 98
Novel Insight into Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Gaykalova, D. A., Mambo, E., Choudhary, A. K., Houghton, J., Buddavarapu, K., Sanford, T., Darden, W., Adai, A. T., Hadd, A. G., Latham, G. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093102 · Cited by 99
Priebe, A. M., Tan, L., Wahl, H. N., Kueck, A. S., He, G., Kwok, R. P. S., Opipari, A. W., & Liu, J. R. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.04.024 · Cited by 92
Redox-Based Escape Mechanism from Death: The Cancer Lesson
Pani, G., Giannoni, E., Galeotti, T., & Chiarugi, P. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2739 · Cited by 91
Toyama, T., Kondo, N., Endo, Y., Sugiura, H., Yoshimoto, N., Iwasa, M., Takahashi, S., Fujii, Y., & Yamashita, H. (2012) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hys001 · Cited by 96
Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response
Huang, X., & Zuo, J. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt141 · Cited by 97
Kaymak, I., Maier, C. R., Schmitz, W., Campbell, A. D., Dankworth, B., Ade, C. P., Walz, S., Paauwe, M., Kalogirou, C., Marouf, H., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-0650 · Cited by 89
Wei, L., Zhou, Y., Qiao, C., Ni, T., Li, Z., You, Q., Guo, Q., & Lu, N. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.86 · Cited by 93
Biswas, S., Troy, H., Leek, R., Chung, Y.-L., Li, J.-L., Raval, R. R., Turley, H., Gatter, K., Pezzella, F., Griffiths, J. R., et al. (2010) · Journal of Oncology · doi:10.1155/2010/757908 · Cited by 89
Petrelli, F., Ardito, R., Merelli, B., Lonati, V., Cabiddu, M., Seghezzi, S., Barni, S., & Ghidini, A. (2018) · Melanoma Research · doi:10.1097/cmr.0000000000000520 · Cited by 90
Itaconate: an emerging determinant of inflammation in activated macrophages
Yu, X., Zhang, D., Zheng, X., & Tang, C. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12218 · Cited by 92
Meng, L., Zhang, Y., Wu, P., Li, D., Lu, Y., Shen, P., Yang, T., Shi, G., Chen, Q., Yuan, H., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01599-5 · Cited by 90
LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic process
Qin, Y., Zhu, W., Xu, W., Zhang, B., Shi, S., Ji, S., Liu, J., Long, J., Liu, C., Liu, L., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.013 · Cited by 92
Blockage of citrate export prevents TCA cycle fragmentation via Irg1 inactivation
Li, Y., Li, Y., Liu, X.-T., Zhang, L., Chen, Y.-H., Zhao, Q., Gao, W. Y., Liu, B., Yang, H. Q., & Li, P. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110391 · Cited by 97
The role of hypoxia-inducible factors in cardiovascular diseases
Yu, B., Wang, X., Song, Y., Xie, G., Jiao, S., Shi, L., Cao, X., Han, X., & Qu, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108186 · Cited by 90
The altered metabolism of tumors: HIF-1 and its role in the Warburg effect
Stubbs, M., & Griffiths, J. R. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.027 · Cited by 97
Metadata
- Authors
- Denko, N. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Denko, Nicholas C.
- ORCID
- Denko, Nicholas C.
- Venue
- Nature Reviews Cancer
- Published
- 2008-08-14
- Volume
- 8
- Issue
- 9
- Pages
- 705-713
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2066379425
- Cited by
- 1,707
- References
- 126
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 93 · 2023: 113 · 2022: 141 · 2021: 149 · 2020: 115 · 2019: 120 · 2018: 126 · 2017: 94 · 2016: 115 · 2015: 78 · 2014: 95 · 2013: 79 · 2012: 77
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P01CA067166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- hypoxia, HIF-1, glucose metabolism, solid tumors, aerobic glycolysis, Warburg effect, cancer metabolism, mitochondrial activity, tumor growth
- MeSH terms
- Cell Division, Glucose, Glycolysis, Humans, Mitochondria, Models, Biological, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.